Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liposomal vs Intravenous Iron in CKD
NCT01864161Phase 4Completed
- Sponsor
- University of Naples Federico II
- Start
- Oct 2011
- Primary completion
- May 2013
- Modality
- Nanoparticles
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of sucrosomial iron in iron deficiency anemia (IDA) (2 arms), sponsored by University of Naples Federico II. Primary endpoint: modification in hemoglobin levels at 3 months. Started Oct 2011; status: completed.
02
Drugs
sucrosomial iron
03
Conditions
iron deficiency anemia (IDA)
Beyond the preview
Go deeper on NCT01864161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01864161.